Treatment with psychopharmaca during pregnancy - Part I: Aslittle as possible but as much as necessary;Die Behandlung mit Psychopharmaka in der Schwangerschaft- Teil I: Sowenig wie möglich, abersoviel wie nötig

Fortschritte der Neurologie Psychiatrie

Volumn 80, Issue 4, 2012, Pages 227-240

  Rohde, A ^a   Dorsch, V M ^b   Schaefer, C ^c  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; PREGNANCY; PSYCHOPHARMACOLOGY;

ADULT; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; CONTRACEPTION; FEMALE; FERTILITY; HUMANS; LITHIUM COMPOUNDS; MENTAL DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOTROPIC DRUGS; RISK ASSESSMENT;

EID: 84859199357     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0031-1299314     Document Type: Article

References (41)

1. Monitor Familienleben 2010. Allensbach Institut für Demoskopie 2010 Im Internet http://www.ifd-allensbach.de; Stand: 25.04.2011
2. Marneros A, Deister A, Rohde A. Affektive, schizoaffektive und schizophrene Psychosen. Berlin Springer 1991
3. Rohde A. Psychische Störungen und Reproduktion. In: Marneros A Rohde A (Hrsg) Geschlechtsspezifische Psychiatrie und Psychotherapie. Stuttgart Kohlhammer 2007 512-519
4. Krumm S, Kilian R, Becker T. Ich werde sie sicherlich nicht einfach so in die Welt setzen. Der soziale Kontext des Kinderwunschs aus der Sicht von Frauen mit psychischen Erkrankungen. Psychiat Prax 2011 38 23-30
5. Kendell R E., Chalmers J C., Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry 1987 150 662-673 (Pubitemid 17061231)
6. Harlow B L., Vitonis A F., Sparen P et al. Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal psychiatric hospitalizations. Arch Gen Psychiatry 2007 64 42-48 (Pubitemid 46041737)
7. Grof P, Robbins W, Alda M et al. Protective effect of pregnancy in women with lithium-responsive bipolar disorder. JAffect Disord 2000 61 31-39
8. Cohen L S., Altshuler L L., Harlow B L. et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006 295 499-507 (Pubitemid 43200344)
9. Viguera A C., Nonacs R, Cohen L S. et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000 157 179-184 (Pubitemid 30080895)
10. Viguera A C., Whitfield T, Baldessarini R J. et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007 164 1817-1824 (Pubitemid 351739234)
11. Milgrom J, Gemmill A W., Bilszta J L. et al. Antenatal risk factors for postnatal depression: a large prospective study. JAffect Disord 2008 108 147-157
12. Schaefer C, Spielmann H, Vetter K et al,. Arzneimittel in Schwangerschaft und Stillzeit. 8. Aufl München Elsevier/Urban & Fischer 2011
13. Lund N, Pedersen L H., Henriksen T B. Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med 2009 163 949-954
14. Banach R, Boskovic R, Einarson T et al. Long-term developmental outcome of children of women with epilepsy, unexposed or exposed prenatally to antiepileptic drugs: a meta-analysis of cohort studies. Drug Saf 2010 33 73-79
15. Zeskind P S., Stephens L E. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004 113 368-375 (Pubitemid 38177090)
16. Rice F, Harold G T., Boivin J et al. The links between prenatal stress and offspring development and psychopathology: disentangling environmental and inherited influences. Psychol Med 2010 40 335-345
17. Lee H C., Lin H C. Maternal bipolar disorder increased low birthweight and preterm births: a nationwide population-based study. JAffect Disord 2010 121 100-105
18. Rohde A, Schaefer C. Psychopharmakotherapie in Schwangerschaft und Stillzeit. Arzneisicherheit - Beratung - Entscheidungsfindung. 3. Aufl Stuttgart Thieme 2010
19. Davis R L., Rubanowice D, McPhillips H et al. HMO Research Network Center for Education, Research in Therapeutics. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf 2007 16 1086-1094 (Pubitemid 350020061)
20. Ellfolk M, Malm H. Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs). Reprod Toxicol 2010 30 249-260
21. Reis M, Källén B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010 40 1723-1733
22. Pederson L H., Henriksen T B., Vestergaar M et al. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 2009 339 b3569
23. Colvin L, Slack-Smith L, Stanley F J. et al. Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy. Birth Defects Res A Clin Mol Teratol 2011 91 142-152
24. Gentile S, Galbally M. Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review. JAffect Disord 2011 128 1-9
25. Scialli A R., Iannucci A R. Whole embryo culture and the identification of teratogenicity. Reprod Toxicol 2010 29 247-248
26. Hallberg P, Sjöblom V. The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects. JClin Psychopharmacol 2005 25 59-73 (Pubitemid 40129383)
27. Oberlander T F., Warburton W, Misri S et al. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol 2008 83 68-76 (Pubitemid 351317794)
28. Wichman C L., Moore K M., Lang T R. et al. Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy. Mayo Clin Proc 2009 84 23-27
29. Scialli A R. Paroxetine exposure during pregnancy and cardiac malformations. Birth Defects Res A Clin Mol Teratol 2010 88 175-177
30. Rohde A, Dembinski J, Dorn C. Mirtazapine (Remergil) for treatment resistant hyperemesis gravidarum: rescue of a twin pregnancy. Arch Gynecol Obstet 2003 268 (3) 219-221 (Pubitemid 36988464)
31. Gentile S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull 2010 36 518-544
32. Reis M, Källén B. Maternal use of antipsychotics in early pregnancy and delivery outcome. JClin Psychopharmacol 2008 28 279-288
33. Yacobi S, Ornoy A. Is lithium a real teratogen? What can we conclude from the prospective versus retrospective studies? A review. Isr J Psychiatry Relat Sci 2008 45 95-106
34. Harden C L., Meador K J., Pennell P B. et al. Practice parameter update: management issues for women with epilepsy - focus on pregnancy: teratogenesis and perinatal outcomes. Neurology 2009 73 133-141
35. Dolk H, Jentink J, Loane M et al. EUROCAT Antiepileptic Drug Working Group. Does lamotrigine use in pregnancy increase orofacial cleft risk relative to other malformations? Neurology 2008 71 714-722
36. Hunt S J., Craig J J., Morrow J I. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 2009 72 1108
37. Holmes L B., Baldwin E J., Smith C R. et al. Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy. Neurology 2008 70 2152-2158
38. Vajda F J., Graham J E., Hitchcock A A. et al. Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register. Seizure 2010 19 558-561
39. Williams G, King J, Cunningham M et al. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 2001 43 202-206 (Pubitemid 32233082)
40. Matalon S, Schechtman S, Goldzweig G et al. The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures. Reprod Toxicol 2002 16 9-17 (Pubitemid 34308448)
41. Dolovich L R., Addis A, Vaillancourt J M. et al. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ 1998 317 839-843 (Pubitemid 28434551)